SeaStar Medical (ICU) Stock Price, News & Analysis

Company Overview

SeaStar Medical, Inc. (NASDAQ: ICU) is a medical device company focused on the development and commercialization of cerebral embolic protection systems for patients undergoing transcatheter aortic valve replacement (TAVR) procedures. The company’s mission is to reduce the risk of stroke and other neurologic events associated with structural heart interventions by capturing or deflecting embolic debris that can travel to the brain during catheter-based therapies.

The company’s flagship product, TriGUARD® 3, is a next-generation embolic deflection device designed to provide coverage of all three cerebral vessels during TAVR. TriGUARD 3 features an advanced frame and filter design that conforms to varying patient anatomies, enabling physicians to position the device safely and effectively without obstructing critical arterial access routes. SeaStar Medical continues to invest in clinical trials and registry studies to demonstrate the safety and performance of its technology and to support regulatory clearances in North America, Europe and other key markets.

Headquartered in Kansas City, Missouri, SeaStar Medical serves a global customer base through direct sales and distribution partnerships in Europe and parts of Asia Pacific, in addition to its U.S. operations. The company collaborates with interventional cardiologists, cardiac surgeons and research institutions to refine device design and expand indications. Its leadership team brings extensive experience from leading cardiovascular and medical device firms, guiding SeaStar Medical through product development, regulatory interactions and market introduction efforts to address the growing demand for neuroprotection in structural heart care.

Key Stats

• Today's Range: $2.84 to $3.01
• 50-Day Range: $2.88 to $5.08
• 52-Week Range: $2.07 to $12.50
• Volume: 25,519 shs
• Average Volume: 67,667 shs
• Market Capitalization: $13.14 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $8.00
• Consensus Rating: Hold

SeaStar Medical Stock Analysis - MarketRank™

SeaStar Medical scored higher than 54% of companies evaluated by MarketBeat, and ranked 426th out of 906 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.2 / 5
• Analyst Rating: Hold

Consensus Rating

SeaStar Medical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.

Upside Potential

SeaStar Medical has a consensus price target of $8.00, representing about 168.5% upside from its current price of $2.98.

Amount of Analyst Coverage

SeaStar Medical has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for SeaStar Medical are expected to grow in the coming year, from ($3.66) to ($2.09) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of SeaStar Medical is -0.76, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of SeaStar Medical is -0.76, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

SeaStar Medical has a P/B Ratio of 1.08. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.78% of the float of SeaStar Medical has been sold short.

Short Interest Ratio / Days to Cover

SeaStar Medical has a short interest ratio ("days to cover") of 1.32, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in SeaStar Medical has recently increased by 33.46%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

SeaStar Medical does not currently pay a dividend.

Dividend Growth

SeaStar Medical does not have a long track record of dividend growth.

News and Social Media

• Score: N/A
• News Sentiment: N/A

Company Ownership

• Score: 2.9 / 5
• Insider Trading: Acquiring Shares

Net Insider Buying

Over the last three months, insiders have purchased a net $2,452.00 in company stock, which represents 0.0187% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, SeaStar Medical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $2,452.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

0.70% of the stock of SeaStar Medical is held by insiders.

Percentage Held by Institutions

1.69% of the stock of SeaStar Medical is held by institutions.

Company Calendar

• Last Earnings: 8/12/2026
• Today: 9/07/2026
• Next Earnings (Estimated): 11/12/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:ICU
• CIK: 1831868
• Web: seastarmedical.com
• Phone: 844-427-8100
• Fax: N/A
• Employees: 2
• Year Founded: N/A

Price Target and Rating

• Average Price Target for SeaStar Medical: $8.00
• High Price Target: $8.00
• Low Price Target: $8.00
• Potential Upside/Downside: +168.5%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): ($3.91)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$12.15 million
• Net Margins: -795.51%
• Pretax Margin: -795.33%
• Return on Equity: -162.75%
• Return on Assets: -109.89%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.89
• Quick Ratio: 1.87

Sales & Book Value

• Annual Sales: $1.23 million
• Price / Sales: 10.68
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $2.75 per share
• Price / Book: 1.08

Miscellaneous

• Outstanding Shares: 4,410,000
• Free Float: 4,376,000
• Market Cap: $13.14 million
• Optionable: Not Optionable
• Beta: -1.05